Novonix Ltd Adr Stock Performance

NVX Stock  USD 1.18  0.01  0.85%   
The company secures a Beta (Market Risk) of 1.02, which conveys a somewhat significant risk relative to the market. Novonix returns are very sensitive to returns on the market. As the market goes up or down, Novonix is expected to follow. At this point, Novonix Ltd ADR has a negative expected return of -0.51%. Please make sure to verify Novonix's market facilitation index, relative strength index, as well as the relationship between the rate of daily change and kurtosis , to decide if Novonix Ltd ADR performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novonix Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1
Novonix enters licensing deal for furnace tech
01/13/2025
2
Novonix Shares Outperform ASX 200 After Oversubscribed Share Purchase Plan
01/15/2025
3
NOVONIX Limited Insider Anthony Bellas Buys 44,464 Shares
01/17/2025
4
Novonix CEO Burns set to step down Long to become interim CEO
01/21/2025
5
Why NOVONIX Limited Is Among the Best ASX Stocks to Buy According to Hedge Funds
01/31/2025
6
ASX Lunch Wrap Shares free-fall on Trumps tariffs, as traders await Chinas countermeasures
02/03/2025
7
Novonix Adjusts Production Timeline Amid Supply Chain Delays
02/20/2025
8
Discretionary transaction by Bank Of America Corp de of tradable shares of Novonix subject to Rule 16b-3
02/26/2025
9
ASX Market Close Index Drops Amid Growing Concerns Over Trump
03/13/2025
10
NOVONIX Limited Short Interest Down 29.8 percent in February
03/18/2025
Begin Period Cash Flow78.7 M
  

Novonix Relative Risk vs. Return Landscape

If you would invest  170.00  in Novonix Ltd ADR on December 21, 2024 and sell it today you would lose (52.00) from holding Novonix Ltd ADR or give up 30.59% of portfolio value over 90 days. Novonix Ltd ADR is generating negative expected returns assuming volatility of 4.6048% on return distribution over 90 days investment horizon. In other words, 41% of stocks are less volatile than Novonix, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Novonix is expected to under-perform the market. In addition to that, the company is 5.41 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of volatility.

Novonix Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Novonix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Novonix Ltd ADR, and traders can use it to determine the average amount a Novonix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1113

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNVX

Estimated Market Risk

 4.6
  actual daily
41
59% of assets are more volatile

Expected Return

 -0.51
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Novonix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novonix by adding Novonix to a well-diversified portfolio.

Novonix Fundamentals Growth

Novonix Stock prices reflect investors' perceptions of the future prospects and financial health of Novonix, and Novonix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novonix Stock performance.

About Novonix Performance

Evaluating Novonix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Novonix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Novonix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 285.30  299.56 
Return On Tangible Assets(0.35)(0.33)
Return On Capital Employed(0.20)(0.21)
Return On Assets(0.33)(0.35)
Return On Equity(0.54)(0.57)

Things to note about Novonix Ltd ADR performance evaluation

Checking the ongoing alerts about Novonix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Novonix Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Novonix Ltd ADR generated a negative expected return over the last 90 days
Novonix Ltd ADR may become a speculative penny stock
Novonix Ltd ADR has high historical volatility and very poor performance
The company reported the last year's revenue of 5.85 M. Reported Net Loss for the year was (74.82 M) with profit before taxes, overhead, and interest of 4.08 M.
Novonix Ltd ADR has about 207.08 M in cash with (40.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Novonix Ltd ADR has a poor financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: NOVONIX Limited Short Interest Down 29.8 percent in February
Evaluating Novonix's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Novonix's stock performance include:
  • Analyzing Novonix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novonix's stock is overvalued or undervalued compared to its peers.
  • Examining Novonix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Novonix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novonix's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Novonix's stock. These opinions can provide insight into Novonix's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Novonix's stock performance is not an exact science, and many factors can impact Novonix's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.